The Future of syringe therapy
De-Risking Disease Acquisition and Toxin Intake via Syringe Drug Delivery
About Syringys
Our Company and Vision
SYRINGYS LLC is a startup product development company located in New York City. We are advancing devices which incorporate pre-filled sterile air for use with syringes to avoid contamination with ambient air. SYRINGYS’ approach utilizes adaptive, sterile air containment systems to prevent the microscopic transmission of airborne diseases and toxins during drug delivery via syringe/needle and syringe/intravenous therapy modalities. The global syringe market was $22 billion in 2023. Costs associated with hospital acquired infections (HAI) rose to $32 billion in 2023. We believe our products will greatly improve health, decrease healthcare costs, and save lives.
Revolutionizing DRUG DELIVERY
Precision Drug Delivery
Developing revolutionary pre-filled sterile air devices to avoid contamination with ambient air. We work on developing innovative drug delivery systems that improve the efficacy and safety of drugs. Our team uses advanced designs to create delivery systems that can improve health of patients and avoid many hospital acquired infections.
Leading a Global Revolution
SYRINGYS is pioneering a global revolution to protect drug delivery and prevent cross-contamination. Through invention, science, and technology, SYRINGYS is committed to reclaiming what has been overlooked, offering the transformative gift of sterile drug delivery.
Medical Devices
Our intellectual property designs for medical devices improve the lives of patients. We use innovative designs to create devices that are more effective, less dangerous, and more beneficial for patients.